rss
Heart 2009;95:1593-1599 doi:10.1136/hrt.2008.164426
  • Original article
  • Coronary artery disease

Determinants and outcomes of coronary angiography after non-ST-segment elevation myocardial infarction. A cohort study of the Myocardial Ischaemia National Audit Project (MINAP)

  1. J S Birkhead1,
  2. C F M Weston2,
  3. R Chen3
  1. 1
    National Institute for Clinical Outcomes Research, The Heart Hospital, London, UK
  2. 2
    The School of Medicine, Swansea University, Singleton Park, Swansea, UK
  3. 3
    University College London Medical School, London, UK
  1. Correspondence to Dr C F M Weston. The School of Medicine, Swansea University, Singleton Park, Swansea SA2 8PP, UK; c.f.m.weston{at}swansea.ac.uk
  • Accepted 10 March 2009
  • Published Online First 8 June 2009

Abstract

Objective: To investigate determinants of, and outcomes from, coronary angiography and intervention in patients with non-ST-segment elevation myocardial infarction (NSTEMI).

Design: Observational study.

Setting: 44 British hospitals with interventional facilities.

Patients: 13 489 admissions with NSTEMI; July 2005 to December 2006.

Main outcome measures: Rate of angiography during index admission; death and readmission to hospital within 180 days.

Results: Significantly lower rates of angiography were seen for women, the elderly, the most deprived and those having cardiac, and most non-cardiac, comorbidities. Performance of angiography, compared with no angiography, was not associated with lower rate of readmission (multiple adjusted hazard ratio (HR) = 0.96, 95% CI 0.74 to 1.24) unless accompanied by coronary intervention (HR = 0.73, 95% CI 0.56 to 0.95). Angiography was associated with reduction in 180-day mortality for survivors of hospitalisation (HR = 0.59, 95% CI 0.49 to 0.72); with greater reduction when followed by an intervention (HR = 0.34, 95% CI 0.28 to 0.42). This mortality benefit after intervention was seen both in women (HR = 0.42, 95% CI 0.29 to 0.60) and men (HR = 0.31, 95% CI 0.24 to 0.41), and across age groups: <65 years (HR = 0.25, 95% CI 0.14 to 0.44), 65–79 years (HR = 0.29, 95% CI 0.22 to 0.39) and ≥80 years (HR = 0.52, 95% CI 0.37 to 0.74). Mortality benefit was not significantly attenuated by the presence of comorbidities.

Conclusion: Performance of angiography and coronary intervention after NSTEMI was associated with mortality benefit that persisted in the presence of both cardiac and non-cardiac comorbidities. Mortality benefit was seen across age groups and was similar for both sexes.

Footnotes

  • Funding MINAP is funded by the Healthcare Quality Improvement Partnership.

  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.

This Article

  1. All Versions of this Article:
    1. hrt.2008.164426v1
    2. 95/19/1593 most recent

Services

  1. Request permissions

Responses

  1. Submit a response
  2. No responses published

Social bookmarking

Latest from Education in Heart

Latest from Education in Heart

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Heart.
View free sample issue >>

Free archive
The full back archive is now available for Heart. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.